RIPK1 and myeloid sarcoma: The overlapping inflammation-related signature suggests RIPK1 signaling in CNS cells may regulate various cytokines and chemokines implicated in MS pathogenesis (Figure 4J; Göbel et al., 2018; Jafarzadeh et al., 2014; Khaibullin et al., 2017; Li et al., 2017; Ofengeim et al., 2017; Seppi et al., 2014; Soleimani et al., 2019).